Recombinant wild type 1 birch allergy vaccine (Biomay/Stallergenes)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant wild type 1 birch allergy vaccine (Biomay/Stallergenes)
Drug Alias NamerBet V-1rBet V-1a
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsRhinitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStallergenes Greer
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStallergenes GreerBiomay Ag
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A